Natco Pharma Ltd Annually Results

Gross Sales

4,429.5

3,998.8

2,707.1

1,944.8

2,052.1

Excise Duty

0

0

0

0

0

Net Sales

4,429.5

3,998.8

2,707.1

1,944.8

2,052.1

Other Operating Income

0

0

0

0

0

Other Income

354.5

128.1

104.6

99

103.6

Total Income

4,784

4,126.9

2,811.7

2,043.8

2,155.7

Total Expenditure

2,233.5

2,247.4

1,771.5

1,681.3

1,445.9

PBIDT

2,550.5

1,879.5

1,040.2

362.5

709.8

Interest

23.9

19.2

14.5

17.7

13.3

PBDT

2,526.6

1,860.3

1,025.7

344.8

696.5

Depreciation

235.2

186.8

163.8

142.6

116.9

Minority Interest Before NP

0

0

0

0

0

Tax

437.6

316.5

162.7

47.8

147.8

Deferred Tax

-29.6

-31.3

-16.1

-15.6

-10.6

Reported Profit After Tax

1,883.4

1,388.3

715.3

170

442.4

Minority Interest After NP

-2

0

0

0

1.5

Net Profit after Minority Interest

1,885.4

1,388.3

715.3

170

440.9

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

1,885.4

1,388.3

715.3

170

440.9

EPS (Unit Curr.)

105.26

77.34

39.18

9.32

24.2

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

300

475

275

225

262.5

Equity

35.8

35.8

36.5

36.5

36.5

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

57.57

47

38.42

18.63

34.58

PBDTM(%)

57.04

46.52

37.88

17.72

33.94

PATM(%)

42.51

34.71

26.42

8.74

21.55